Trial intelligence / Profile preview

ATTAACH: Anticoagulation Timing in AF after SDH

NCT05472766Terminated

Sponsor
Sunnybrook Health Sciences Centre
Start
Nov 2022
Primary completion
Mar 2024
Countries
1
01

Overview

Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by Sunnybrook Health Sciences Centre. Primary endpoints: Recruitment rate at 1 year and Implementation of study protocol at 2.5 years. Started Nov 2022; status: terminated.

02

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT05472766.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05472766.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call